McGuire Investment Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,477
Closed -$5.18M 113
2025
Q1
$5.18M Buy
30,477
+371
+1% +$64.4K 0.77% 41
2024
Q4
$5M Sell
30,106
-8
-0% -$1.37K 0.72% 42
2024
Q3
$5.18M Sell
30,114
-533
-2% -$88.2K 0.73% 43
2024
Q2
$4.72M Sell
30,647
-126
-0.4% -$18.9K 0.68% 41
2024
Q1
$4.73M Buy
30,773
+1,648
+6% +$251K 0.69% 41
2023
Q4
$4.6M Sell
29,125
-59
-0.2% -$8.48K 0.77% 38
2023
Q3
$4.27M Buy
29,184
+1,496
+5% +$228K 0.82% 37
2023
Q2
$4.24M Sell
27,688
-711
-3% -$111K 0.79% 37
2023
Q1
$4.4M Sell
28,399
-359
-1% -$56.4K 0.88% 37
2022
Q4
$4.43M Buy
28,758
+280
+1% +$41.3K 0.96% 36
2022
Q3
$3.76M Sell
28,478
-668
-2% -$93.7K 0.86% 40
2022
Q2
$3.95M Buy
+29,146
New +$4.02M 0.85% 39
2022
Q1
Sell
-29,427
Closed -$4.77M 128
2021
Q4
$4.77M Sell
29,427
-1,996
-6% -$323K 0.78% 37
2021
Q3
$5.22M Buy
31,423
+525
+2% +$89.7K 0.98% 37
2021
Q2
$5.33M Buy
+30,898
New +$5.1M 1.01% 39
2020
Q4
Sell
-27,319
Closed -$4.3M 97
2020
Q3
$4.3M Buy
+27,319
New +$4.47M 1.28% 31
2019
Q4
Sell
-27,805
Closed -$3.44M 92
2019
Q3
$3.44M Sell
27,805
-1,690
-6% -$225K 1.13% 37
2019
Q2
$4.15M Buy
29,495
+356
+1% +$49.1K 1.32% 30
2019
Q1
$4.4M Buy
29,139
+141
+0.5% +$20.3K 1.44% 27
2018
Q4
$3.6M Buy
28,998
+345
+1% +$47.2K 1.36% 27
2018
Q3
$4.54M Buy
+28,653
New +$4.34M 1.5% 27

Other funds holding FBT

McGuire Investment Group's FBT Position: Q2 2025 in Review

McGuire Investment Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2025, closing a stake of 30,477 shares — an estimated $5.18M sold.

McGuire Investment Group first reported a position in FBT in Q3 2018 and held it in 21 quarters. The position peaked at $5.33M in Q2 2021. 250 funds tracked by Wall St. Rank hold FBT as of Q2 2025.

  • McGuire Investment Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2025 after selling out during the quarter.
  • McGuire Investment Group sold 30,477 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2025, an estimated $5.18M.
  • McGuire Investment Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 21 quarters.
  • McGuire Investment Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $5.33M in Q2 2021.
  • 250 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2025.

Based on McGuire Investment Group's 13F filing for Q2 2025, filed 18 Jul 2025.